Swedish Cancer Society Awards SEK 57.85 Million to OnkPat Researchers

Seventeen researchers at the Department of Oncology-Pathology (OnkPat) have been awarded a total of SEK 57.85 million in research grants in the Swedish Cancer Society's latest funding round. The projects span several areas of cancer research, including precision medicine, diagnostics and new treatment strategies.

Karolinska Institutet is the largest recipient in the Swedish Cancer Society's latest funding round. Researchers at 16 KI departments have been awarded approximately SEK 352 million across 98 grants. The funding round comprises more than SEK 916 million for Swedish cancer research, distributed across 247 grants at 13 Swedish higher education institutions.

At OnkPat, the following researchers have been awarded grants:

Tina Dalianis

Project: Targeted Monitoring and Precision Therapy in Human Papillomavirus (HPV)-Driven Head and Neck Cancer

Grant awarded: SEK 4,500,000, 2027-2029.

Lars Egevad

Project: Artificial Intelligence and Genetics for Diagnosis and Prognosis of Prostate Cancer

Grant awarded: SEK 2,000,000, 2027-2028.

Simon Ekman

Project: Overcoming Resistance to Targeted Therapies in Lung Cancer - Novel Therapeutics using a Multiomics Approach

Grant awarded: SEK 3,000,000, 2027-2029.

Martin Enge

Project: Genetic determinants of oncogenic transcriptional regulation in pediatric ALL by large-scale allelic footprinting and deep learning

Grant awarded: SEK 4,500,000, 2027-2029.

Anita Göndör

Project: Circadian oncogene gating: a noise-generating mechanism driving cancer evolution

Grant awarded: SEK 1,600,000, 2027-2028.

Johan Hartman

Project: From Dichotomy to Continuum: Advancing Estrogen Receptor Assessment for Breast Cancer Precision Oncology

Grant awarded: SEK 3,750,000, 2027-2029.

Lars Holmgren

Project: AmotL2 isoform-dependent mechanonuclear coupling and epigenetic modulation in invasive cancer

Grant awarded: SEK 4,500,000, 2027-2029.

Rozbeh Jafari

Project: Proteoform-guided precision therapy in acute lymphoblastic leukemia through integrative multi-omics

Grant awarded: SEK 3,000,000, 2027-2029.

Christofer Juhlin

Project: Deciphering Dedifferentiation and Radioiodine Resistance in Thyroid Cancer: Integrated Multi-Omics and Functional Approaches for Precision Oncology

Grant awarded: SEK 4,500,000, 2027-2029.

Kasper Karlsson

Project: Improving radioligand therapy response in neuroblastoma through rational radiosensitization

Grant awarded: SEK 3,000,000, 2027-2029.

Catharina Larsson

Project: Molecular, clinical and functional aspects of endocrine tumor development - a precision medicine approach

Grant awarded: SEK 4,500,000, 2027-2029.

Janne Lehtiö

Project: Translating chromosomal aberrations into therapeutic targets through proteome network analysis of breast cancer

Grant awarded: SEK 6,000,000, 2027-2029.

Wengonn Lui

Project: Definining viral oncoprotein-driven networks and CD44 regulation to reveal therapeutic vulnerabilities in Merkel cell carcinoma

Grant awarded: SEK 3,000,000, 2027-2029.

Anders Näsman

Project: Diagnostic and Prognostic Markers in Head and Neck Cancer: Focus on Oropharyngeal Squamous Cell Carcinoma (OPSCC), Oral Squamous Cell Carcinoma (OSCC) and Malignant Salivary Gland Tumors (MST).

Grant awarded: SEK 3,000,000, 2027-2029.

Sean Rudd

Project: Towards a mechanistic basis for precision antimetabolite therapy in cancer

Grant awarded: SEK 3,000,000, 2027-2029.

Nicholas Tobin

Project: Deconstructing and rebuilding tumours: AI and single-cell analysis for cancer biology and risk stratification

Grant awarded: SEK 3,000,000, 2027-2029.

Kenny Wallberg

Project: Accelerated Aging, Reproductive Aging and Biological Vulnerability in Childhood, Adolescence and Young Adulthood Cancer Survivors

Grant awarded: SEK 1,000,000, 2027.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.